This episode details the specific steps and documentation required to list an FDA-cleared medical device on Australia's Australian Register of Therapeutic Goods (ARTG). We explore how leveraging your existing FDA approval can streamline the TGA inclusion process, the critical role of an Australian Sponsor, and the importance of recent regulatory updates effective in late 2024. • Is my FDA clearance automatically accepted in Australia? • What is the very first step for a foreign manufacturer to enter the Australian market? • Which specific FDA documents does the TGA accept as evidence? • What is an Australian Declaration of Conformity and is it required? • Do I need a new Quality Management System certificate for Australia? • How can I use my existing clinical data for the TGA application? • What is the key regulatory change happening on October 19, 2024? • What are my responsibilities after my device is listed on the ARTG? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.